SCHEMBL714739

SCHEMBL714739

CCCCCCCC/C=C\CCCCCCCC(=O)O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.59
PRKCE Q02156 1/20 0.59
PRKCQ Q04759 1/20 0.59
PRKCD Q05655 1/20 0.59
DGKA P23743 1/20 0.58
FAAH O00519 3/20 0.56
MAPT P10636 2/20 0.56
CNR2 P34972 2/20 0.56
ALDH1A1 P00352 1/20 0.56
HPGD P15428 1/20 0.56
CNR1 P21554 1/20 0.56
MAPK1 P28482 1/20 0.51
DEGS1 O15121 1/20 0.51
S1PR1 P21453 1/20 0.51
LPAR1 Q92633 5/20 0.49
ENPP2 Q13822 2/20 0.49
LPAR4 Q99677 2/20 0.49
LPAR5 Q9H1C0 2/20 0.49
LPAR2 Q9HBW0 2/20 0.49
LPAR3 Q9UBY5 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL709550 1.00 PRKCA (0.59) PRKCAPRKCEPRKCQPRKCDDGKA
Ether SCHEMBL19971727 0.95 PRKCA (0.54) PRKCAPRKCEPRKCQPRKCDDGKA
Oxirane SCHEMBL11211813 0.94 DGKA (0.55) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL714245 0.92 MAPT (0.60) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL715876 0.92 MAPT (0.60) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL3250346 0.92 MAPT (0.60) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL6332412 0.89 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDDGKA
Ethylene SCHEMBL21633977 0.89 MAPT (0.57) PRKCAPRKCEPRKCQPRKCDDGKA
Ethylene SCHEMBL7947908 0.89 MAPT (0.57) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL23781814 0.88 PRKCA (0.60) PRKCAPRKCEPRKCQPRKCDDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024142920-A1 OIL-IN-WATER EMULSION COSMETIC 株式会社 資生堂 2024-07-04 WO disclosed
US-20230404877-A1 POWDER-CONTAINING COMPOSITION SHISEIDO COMPANY, LTD. (JP) 2023-12-21 US disclosed
US-20230293417-A1 ADENOSINE-CONTAINING COMPOSITION AND METHOD FOR SUPPRESSING PRECIPITATION OF ADENOSINE SHISEIDO COMPANY, LTD. (JP) 2023-09-21 US disclosed
EP-3666251-B1 POWDER-CONTAINING WATER-BASED COMPOSITION AND EXTERNAL SKIN PREPARATION SHISEIDO CO LTD (JP) 2023-09-06 EP disclosed
EP-4233835-A1 OIL-IN-WATER TYPE COMPOSITION Shiseido Company, Ltd. (JP) 2023-08-30 EP disclosed
US-11730684-B2 Cleansing composition SHISEIDO COMPANY, LTD. (JP) 2023-08-22 US disclosed
EP-2740771-B1 COMPOSITE POWDER AND METHOD FOR PRODUCING SAME SAKAI CHEMICAL INDUSTRY CO (JP) 2023-07-19 EP disclosed
US-20230190626-A1 CLEANSER COMPOSITION SHISEIDO COMPANY, LTD. (JP) 2023-06-22 US disclosed
US-20230190590-A1 LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION, AND COMPOSITION FOR EXTERNAL-USE SKIN PREPARATION SHISEIDO COMPANY, LTD. (JP) 2023-06-22 US disclosed
US-20230142992-A1 THICKENER FOR NON-AQUEOUS COMPOSITIONS SHISEIDO COMPANY, LTD. (JP) 2023-05-11 US disclosed
WO-2005020950-A1 COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE SHOWA DENKO K.K. (JP) 2005-03-10 WO disclosed
WO-2004071481-A1 MELANOGENESIS INHIBITOR AND SKIN PREPARATION CONTAINING THE SAME TAKASAGO INTERNATIONAL CORPORATION (JP) 2004-08-26 WO disclosed
EP-1364943-A1 NOVEL CYSTINE DERIVATIVES AND INHIBITORS FOR THE ACTIVATION OF INFLAMMATORY FACTORS Ajinomoto Co., Inc. (JP) 2003-11-26 EP disclosed
US-20030003071-A1 Hair growth stimulant SHISEIDO COMPANY, LTD. (JP) 2003-01-02 US disclosed
EP-1234574-A1 HAIR GROWTH STIMULANT SHISEIDO COMPANY LIMITED (JP) 2002-08-28 EP disclosed
EP-1174437-A1 MELANOCYTE-STIMULATING HORMONE INHIBITORS Ajinomoto Co., Inc. (JP) 2002-01-23 EP disclosed
EP-0051678-A4 PROCESS FOR PRODUCING SPHERICAL AND POROUS VINYL RESIN PARTICLES. GOODRICH CO B F (US) 1982-11-25 EP disclosed
EP-0051678-A1 PROCESS FOR PRODUCING SPHERICAL AND POROUS VINYL RESIN PARTICLES. GOODRICH CO B F (US) 1982-05-19 EP disclosed
WO-1981003333-A1 PROCESS FOR PRODUCING SPHERICAL AND POROUS VINYL RESIN PARTICLES GOODRICH CO B F (US) 1981-11-26 WO disclosed
US-4217228-A MIXTURE OF HYDROXY- AND HYDROCARBYL-SUBSTITUTED SILICONE OILS TH. GOLDSCHMIDT AG (DE) 1980-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11730684-B2 Cleansing composition DEGS1, SGMS2, SGMS1 PRKCA 1122/4885PRKCE 603/4885PRKCQ 476/4885
US-20230190626-A1 CLEANSER COMPOSITION MGLL, SGMS2, DAGLB PRKCA 2259/4885PRKCE 2837/4885PRKCQ 1879/4885
US-20230142992-A1 THICKENER FOR NON-AQUEOUS COMPOSITIONS DSG1, AQP1, STOM PRKCA 3056/4885PRKCE 2619/4885PRKCQ 2458/4885
US-20230190590-A1 LAMELLAR GEL-CONTAINING COMPOSITION, EMULSIFIED COMPOSITION, AND COMPOSITION FOR EXTERNAL-USE SKIN PREPARATION CUTA, EBP, LIPA PRKCA 450/4885PRKCE 198/4885PRKCQ 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.